Tevogen Bio Inc.
TVGN | NASDAQ
$6.00
+$0.10 (+1.69%)
Nov 2, 2026, 10:37 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 1.08M | 692.31K | 552.37K | 1.04M | 685.23K | 1.97M | 1.28M | 2.33M | 1.14M | 1.32M | 1.05M | 2.61M | 3.46M | 52.28K | 5.48M | 143.05K | 185.65K | 231.55K | 344.58K | n/a |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 25.37M | n/a | 354.12M | 352.38M | 352.06M | 351.92M | n/a |
Other Long-Term Assets | 1.24M | 1.25M | 1.25M | 756.81K | 565.88K | 575.84K | 575.84K | 133.28K | 133.28K | 133.28K | 2.85M | 2.57M | 849.72K | n/a | 594.88K | n/a | n/a | 38.95K | 145.17K | 166.79K |
Receivables | n/a | n/a | 158.82K | 158.82K | 158.82K | 158.82K | 158.82K | 158.82K | 158.82K | 158.82K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | 1.45M | 828.59K | 925.82K | 1.22M | 944.06K | 919.09K | 1.04M | 1.15M | 923.2K | 0 | 0 | 0 | 44.78K | 0 | 275.43K | 409.11K | 502.61K | 446.61K | n/a |
Total Current Assets | 2.01M | 2.14M | 1.54M | 2.12M | 2.06M | 3.08M | 2.36M | 3.53M | 2.45M | 2.4M | 1.72M | 2.76M | 3.67M | 97.06K | 5.84M | 418.47K | 594.76K | 734.16K | 791.19K | n/a |
Property-Plant & Equipment | 1.47M | 1.53M | 1.59M | 1.62M | 1.64M | 419.53K | 524.93K | 628.48K | 730.22K | 830.21K | 928.51K | 1.03M | 1.12M | n/a | 1.31M | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 2.72M | 2.78M | 2.84M | 2.37M | 2.21M | 995.37K | 1.1M | 761.76K | 863.5K | 963.49K | 3.78M | 3.6M | 1.97M | 25.37M | 1.9M | 354.12M | 352.38M | 352.1M | 352.06M | 166.79K |
Total Assets | 4.73M | 4.92M | 4.38M | 4.49M | 4.27M | 4.07M | 3.46M | 4.29M | 3.31M | 3.36M | 5.51M | 6.36M | 5.64M | 25.47M | 7.74M | 354.54M | 352.98M | 352.83M | 352.85M | 166.79K |
Account Payables | 2.83M | 3.8M | 3.34M | 3.31M | 4.24M | 4.66M | 5.2M | 5.84M | 6.67M | 5.21M | 3.42M | 1.89M | 1.11M | n/a | 865.91K | n/a | n/a | n/a | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 1.98M | 1.98M | 1.65M | 1.65M | 1.65M | 1.65M | 1.65M | 2.66M | 1.65M | 1.65M | 80.71M | 63.75M | 62.93M | n/a | n/a | n/a | n/a | n/a | n/a | 81.53K |
Other Current Liabilities | 1.34M | 1.49M | 1.5M | 240.3K | 75.01K | 463.59K | 403.23K | 61.31K | 388.6K | 227.25K | 120.15K | 0 | 251.52K | 667.07K | 237.6K | 281.78K | 259.23K | 179K | 59.38K | 71.67K |
Total Current Liabilities | 6.15M | 7.27M | 7.07M | 6.74M | 8.08M | 8.72M | 9.04M | 10.42M | 10.61M | 8.94M | 85.48M | 67.69M | 64.92M | 667.07K | 1.96M | 281.78K | 259.23K | 179K | 59.38K | 153.2K |
Long-Term Debt | 1.06M | 1.09M | 1.12M | 4.4M | 4.4M | 3M | 1M | n/a | n/a | n/a | 14.22M | 29.21M | 27.3M | n/a | 39.3M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 6.4M | 6.4M | 4.43M | 29.77K | 94.73K | 73.32K | 87.18K | 21.64K | 235.4K | 60.97K | 0 | 0 | 0 | 14.76M | 0 | 14.79M | 14.87M | 15M | 15.12M | n/a |
Total Long-Term Liabilities | 7.47M | 7.49M | 5.55M | 5.58M | 5.67M | 3.07M | 1.09M | 64.2K | 332.21K | 227.76K | 14.45M | 29.47M | 27.61M | 14.76M | 39.73M | 14.79M | 14.87M | 15M | 15.12M | n/a |
Total Liabilities | 13.62M | 14.76M | 12.62M | 12.32M | 13.75M | 11.79M | 10.14M | 10.48M | 10.94M | 9.17M | 99.93M | 97.16M | 92.53M | 15.43M | 41.69M | 15.08M | 15.13M | 15.18M | 15.18M | 153.2K |
Total Debt | 3.04M | 3.07M | 3.1M | 7.53M | 7.56M | 4.82M | 2.89M | 2.96M | 2.02M | 2.08M | 95.42M | 93.51M | 90.83M | n/a | 40.01M | n/a | n/a | n/a | n/a | 81.53K |
Book Value | -8.89M | -9.84M | -8.23M | -7.82M | -9.48M | -7.72M | -6.67M | -6.19M | -7.63M | -5.8M | -94.43M | -90.8M | -86.89M | 10.05M | -33.95M | 339.47M | 337.85M | 337.65M | 337.67M | 13.59K |
Book Value Per Share | -2.32 | -2.82 | -2.48 | -2 | -2.57 | -2.39 | -1.87 | -1.82 | -2.48 | -2.04 | -29.19 | -28.71 | -31.24 | 4.19 | -35.42 | 354.10 | 352.42 | 352.20 | 352.23 | 0.01 |
Common Stock | 426 | 417 | 402 | 19.74K | 19.37K | 18.39K | 17.8K | 17.08K | 16.88K | 16.46K | 12K | 61.88K | 61.88K | 25.37M | 61.88K | 354.13M | 351.9M | 351.9M | 351.9M | 1.2K |
Retained Earnings | -150.87M | -145.11M | -139.66M | -134.98M | -129.26M | -123.75M | -113.39M | -103.94M | -98.06M | -88.39M | -99.66M | -96.03M | -92.12M | -15.33M | -39.18M | -14.66M | -14.05M | -14.26M | -14.23M | -11.41K |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | 0 | n/a | -33.95M | 0 | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | -8.89M | -9.84M | -8.23M | -7.82M | -9.48M | -7.72M | -6.67M | -6.19M | -7.63M | -5.8M | -94.43M | -90.8M | -86.89M | 10.05M | -33.95M | 339.47M | 337.85M | 337.65M | 337.67M | 13.59K |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 25.37M | n/a | 354.12M | 352.38M | 352.06M | 351.92M | n/a |
Add to Watchlist
Select watchlists to add or remove TVGN